New
HealthMore in Health →
Researchers find mRNA cancer vaccines can still rally tumor-killing immunity without a presumed key cell
A Nature study from Washington University in St. Louis found that mRNA cancer vaccines can still trigger strong anti-tumor responses in mice even when a dendritic cell subtype long thought essential is missing.
Key Takeaways
- Researchers tested mRNA cancer vaccination in mice.
- Strong anti-tumor responses persisted even without a dendritic-cell subtype thought essential.
DE
DT Editorial AI··via medicalxpress.com